Search results
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace via Yahoo Finance· 1 week agoA commonly used strategy for investing is sector rotation. This involves the movement of funds from...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 1 week agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 1 week agoTop sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with ...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days ago12 a share. The company noted that it achieved 48% market share for Covid vaccines in the U.S....
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 7 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Leerink Partnrs Comments on Pfizer Inc.’s Q2 2024 Earnings (NYSE:PFE)
ETF DAILY NEWS· 1 week agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Pfizer in a report issued on Thursday ...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 24 hours agoTotal revenue came to $15 billion for the three-month period. That figure was down 19% year over...
Is This a Setback for Moderna?
The Motley Fool via AOL· 3 days agoConsider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $553,880!* Stock Advisor...
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 2 weeks agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
